by Corinne Gangloff
April 17, 2020
As a key contributor to human health, drug-producing industries are expected to continue to operate at normal or near normal capacities despite the COVID-19 pandemic. Thus they will continue to provide demand for a full range of packaging products.
One important segment, plastic and glass pharmaceutical bottles, is forecasted by The Freedonia Group to expand 3.9% annually to $5.8 billion – equivalent to 30.3 billion units – in 2024. Applications in packaging solid oral and liquid medicines, nutritional preparations, and dietary supplements will lead gains. Additionally, this product group will continue to derive sizable demand from use as containers for selected topical and inhalation pharmaceuticals, including ophthalmic solutions, nasal sprays, and dermatological agents. The increasing use of medical and legal recreational marijuana will also boost growth opportunities for plastic and glass jars as well as specialty plastic bottles.
For more information visit the study page for Pharmaceutical Packaging.
https://www.freedoniagroup.com/industry-study/pharmaceutical-packaging-3816.htm
Contact Corinne Gangloff for an interview with the analyst.
Additional Packaging studies can be viewed here:
https://www.freedoniagroup.com/industry-category/pack/packaging.htm
Provide the following details to subscribe.